Global Protein-based Therapeutics Market Growth (Status and Outlook) 2026-2032
The global Protein-based Therapeutics market size is predicted to grow from US$ 275440 million in 2025 to US$ 542810 million in 2032; it is expected to grow at a CAGR of 10.4% from 2026 to 2032.
Protein therapy is a form of treatment that involves sending in well-structured proteins to a precise target location to repair or replace damaged ones. This is one of the most widely used treatment methods due to its accuracy and lack of negative side effects.
The Protein-based Therapeutics Market is driven by the increasing demand for innovative biopharmaceuticals that utilize proteins as therapeutic agents to treat a wide range of diseases, including cancer, autoimmune disorders, and rare genetic conditions. Protein-based therapies, such as monoclonal antibodies and recombinant proteins, offer highly targeted and precise treatment options. As scientific advancements and personalized medicine gain prominence, the demand for protein-based therapeutics continues to grow. Innovations in protein engineering, drug development, and manufacturing technologies further contribute to market expansion. However, a significant challenge for this market is the need to address complex drug development processes, high production costs, and regulatory standards while ensuring accessibility and affordability for patients. Overcoming research and development challenges, optimizing drug manufacturing, and adapting to evolving healthcare regulations are ongoing hurdles. Additionally, the market faces competition from small molecules and gene-based therapies, necessitating continuous innovation to unlock the full therapeutic potential of protein-based drugs. Striking a balance between providing safe, effective, and accessible protein-based therapeutics while addressing scientific and regulatory challenges is essential for the continued growth of the Protein-based Therapeutics Market.
LPI (LP Information)' newest research report, the “Protein-based Therapeutics Industry Forecast” looks at past sales and reviews total world Protein-based Therapeutics sales in 2025, providing a comprehensive analysis by region and market sector of projected Protein-based Therapeutics sales for 2026 through 2032. With Protein-based Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Protein-based Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Protein-based Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Protein-based Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Protein-based Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Protein-based Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Protein-based Therapeutics.
This report presents a comprehensive overview, market shares, and growth opportunities of Protein-based Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by Type:
Protein therapy is a form of treatment that involves sending in well-structured proteins to a precise target location to repair or replace damaged ones. This is one of the most widely used treatment methods due to its accuracy and lack of negative side effects.
The Protein-based Therapeutics Market is driven by the increasing demand for innovative biopharmaceuticals that utilize proteins as therapeutic agents to treat a wide range of diseases, including cancer, autoimmune disorders, and rare genetic conditions. Protein-based therapies, such as monoclonal antibodies and recombinant proteins, offer highly targeted and precise treatment options. As scientific advancements and personalized medicine gain prominence, the demand for protein-based therapeutics continues to grow. Innovations in protein engineering, drug development, and manufacturing technologies further contribute to market expansion. However, a significant challenge for this market is the need to address complex drug development processes, high production costs, and regulatory standards while ensuring accessibility and affordability for patients. Overcoming research and development challenges, optimizing drug manufacturing, and adapting to evolving healthcare regulations are ongoing hurdles. Additionally, the market faces competition from small molecules and gene-based therapies, necessitating continuous innovation to unlock the full therapeutic potential of protein-based drugs. Striking a balance between providing safe, effective, and accessible protein-based therapeutics while addressing scientific and regulatory challenges is essential for the continued growth of the Protein-based Therapeutics Market.
LPI (LP Information)' newest research report, the “Protein-based Therapeutics Industry Forecast” looks at past sales and reviews total world Protein-based Therapeutics sales in 2025, providing a comprehensive analysis by region and market sector of projected Protein-based Therapeutics sales for 2026 through 2032. With Protein-based Therapeutics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Protein-based Therapeutics industry.
This Insight Report provides a comprehensive analysis of the global Protein-based Therapeutics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Protein-based Therapeutics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Protein-based Therapeutics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Protein-based Therapeutics and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Protein-based Therapeutics.
This report presents a comprehensive overview, market shares, and growth opportunities of Protein-based Therapeutics market by product type, application, key players and key regions and countries.
Segmentation by Type:
- Antibody-based Drugs
- Fc Fusion Proteins
- Anticoagulants
- Blood Factors
- Other
- Immune Diseases
- Cancer
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- AbbVie
- Johnson & Johnson
- Novartis
- Gilead Sciences
- Roche
- Bristol-Myers Squibb
- Amgen
- AstraZeneca
- Merck & Co
- Takeda
- Merck KGaA
- Seagen
- Eli Lilly
- Ono Pharmaceutical
- Pfizer
- Regeneron
- Innovent
- Hengrui Medicine
- Sanofi
- Sobi
- Kanghong Pharma
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Protein-based Therapeutics Market Size (2021-2032)
2.1.2 Protein-based Therapeutics Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Protein-based Therapeutics by Country/Region (2021, 2025 & 2032)
2.2 Protein-based Therapeutics Segment by Type
2.2.1 Antibody-based Drugs
2.2.2 Fc Fusion Proteins
2.2.3 Anticoagulants
2.2.4 Blood Factors
2.2.5 Other
2.2.6 Protein-based Therapeutics Market Size by Type
2.2.6.1 Protein-based Therapeutics Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.6.2 Global Protein-based Therapeutics Market Size Market Share by Type (2021-2026)
2.3 Protein-based Therapeutics Segment by Application
2.3.1 Immune Diseases
2.3.2 Cancer
2.3.3 Other
2.3.4 Protein-based Therapeutics Market Size by Application
2.3.4.1 Protein-based Therapeutics Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Protein-based Therapeutics Market Size Market Share by Application (2021-2026)
3 PROTEIN-BASED THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Protein-based Therapeutics Market Size Market Share by Player
3.1.1 Global Protein-based Therapeutics Revenue by Player (2021-2026)
3.1.2 Global Protein-based Therapeutics Revenue Market Share by Player (2021-2026)
3.2 Global Protein-based Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PROTEIN-BASED THERAPEUTICS BY REGION
4.1 Protein-based Therapeutics Market Size by Region (2021-2026)
4.2 Global Protein-based Therapeutics Annual Revenue by Country/Region (2021-2026)
4.3 Americas Protein-based Therapeutics Market Size Growth (2021-2026)
4.4 APAC Protein-based Therapeutics Market Size Growth (2021-2026)
4.5 Europe Protein-based Therapeutics Market Size Growth (2021-2026)
4.6 Middle East & Africa Protein-based Therapeutics Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Protein-based Therapeutics Market Size by Country (2021-2026)
5.2 Americas Protein-based Therapeutics Market Size by Type (2021-2026)
5.3 Americas Protein-based Therapeutics Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Protein-based Therapeutics Market Size by Region (2021-2026)
6.2 APAC Protein-based Therapeutics Market Size by Type (2021-2026)
6.3 APAC Protein-based Therapeutics Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Protein-based Therapeutics Market Size by Country (2021-2026)
7.2 Europe Protein-based Therapeutics Market Size by Type (2021-2026)
7.3 Europe Protein-based Therapeutics Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Protein-based Therapeutics by Region (2021-2026)
8.2 Middle East & Africa Protein-based Therapeutics Market Size by Type (2021-2026)
8.3 Middle East & Africa Protein-based Therapeutics Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PROTEIN-BASED THERAPEUTICS MARKET FORECAST
10.1 Global Protein-based Therapeutics Forecast by Region (2027-2032)
10.1.1 Global Protein-based Therapeutics Forecast by Region (2027-2032)
10.1.2 Americas Protein-based Therapeutics Forecast
10.1.3 APAC Protein-based Therapeutics Forecast
10.1.4 Europe Protein-based Therapeutics Forecast
10.1.5 Middle East & Africa Protein-based Therapeutics Forecast
10.2 Americas Protein-based Therapeutics Forecast by Country (2027-2032)
10.2.1 United States Market Protein-based Therapeutics Forecast
10.2.2 Canada Market Protein-based Therapeutics Forecast
10.2.3 Mexico Market Protein-based Therapeutics Forecast
10.2.4 Brazil Market Protein-based Therapeutics Forecast
10.3 APAC Protein-based Therapeutics Forecast by Region (2027-2032)
10.3.1 China Protein-based Therapeutics Market Forecast
10.3.2 Japan Market Protein-based Therapeutics Forecast
10.3.3 Korea Market Protein-based Therapeutics Forecast
10.3.4 Southeast Asia Market Protein-based Therapeutics Forecast
10.3.5 India Market Protein-based Therapeutics Forecast
10.3.6 Australia Market Protein-based Therapeutics Forecast
10.4 Europe Protein-based Therapeutics Forecast by Country (2027-2032)
10.4.1 Germany Market Protein-based Therapeutics Forecast
10.4.2 France Market Protein-based Therapeutics Forecast
10.4.3 UK Market Protein-based Therapeutics Forecast
10.4.4 Italy Market Protein-based Therapeutics Forecast
10.4.5 Russia Market Protein-based Therapeutics Forecast
10.5 Middle East & Africa Protein-based Therapeutics Forecast by Region (2027-2032)
10.5.1 Egypt Market Protein-based Therapeutics Forecast
10.5.2 South Africa Market Protein-based Therapeutics Forecast
10.5.3 Israel Market Protein-based Therapeutics Forecast
10.5.4 Turkey Market Protein-based Therapeutics Forecast
10.6 Global Protein-based Therapeutics Forecast by Type (2027-2032)
10.7 Global Protein-based Therapeutics Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Protein-based Therapeutics Forecast
11 KEY PLAYERS ANALYSIS
11.1 AbbVie
11.1.1 AbbVie Company Information
11.1.2 AbbVie Protein-based Therapeutics Product Offered
11.1.3 AbbVie Protein-based Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 AbbVie Main Business Overview
11.1.5 AbbVie Latest Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Information
11.2.2 Johnson & Johnson Protein-based Therapeutics Product Offered
11.2.3 Johnson & Johnson Protein-based Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Johnson & Johnson Main Business Overview
11.2.5 Johnson & Johnson Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Protein-based Therapeutics Product Offered
11.3.3 Novartis Protein-based Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 Gilead Sciences
11.4.1 Gilead Sciences Company Information
11.4.2 Gilead Sciences Protein-based Therapeutics Product Offered
11.4.3 Gilead Sciences Protein-based Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Gilead Sciences Main Business Overview
11.4.5 Gilead Sciences Latest Developments
11.5 Roche
11.5.1 Roche Company Information
11.5.2 Roche Protein-based Therapeutics Product Offered
11.5.3 Roche Protein-based Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Roche Main Business Overview
11.5.5 Roche Latest Developments
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Information
11.6.2 Bristol-Myers Squibb Protein-based Therapeutics Product Offered
11.6.3 Bristol-Myers Squibb Protein-based Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Bristol-Myers Squibb Main Business Overview
11.6.5 Bristol-Myers Squibb Latest Developments
11.7 Amgen
11.7.1 Amgen Company Information
11.7.2 Amgen Protein-based Therapeutics Product Offered
11.7.3 Amgen Protein-based Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Amgen Main Business Overview
11.7.5 Amgen Latest Developments
11.8 AstraZeneca
11.8.1 AstraZeneca Company Information
11.8.2 AstraZeneca Protein-based Therapeutics Product Offered
11.8.3 AstraZeneca Protein-based Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 AstraZeneca Main Business Overview
11.8.5 AstraZeneca Latest Developments
11.9 Merck & Co
11.9.1 Merck & Co Company Information
11.9.2 Merck & Co Protein-based Therapeutics Product Offered
11.9.3 Merck & Co Protein-based Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Merck & Co Main Business Overview
11.9.5 Merck & Co Latest Developments
11.10 Takeda
11.10.1 Takeda Company Information
11.10.2 Takeda Protein-based Therapeutics Product Offered
11.10.3 Takeda Protein-based Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Takeda Main Business Overview
11.10.5 Takeda Latest Developments
11.11 Merck KGaA
11.11.1 Merck KGaA Company Information
11.11.2 Merck KGaA Protein-based Therapeutics Product Offered
11.11.3 Merck KGaA Protein-based Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Merck KGaA Main Business Overview
11.11.5 Merck KGaA Latest Developments
11.12 Seagen
11.12.1 Seagen Company Information
11.12.2 Seagen Protein-based Therapeutics Product Offered
11.12.3 Seagen Protein-based Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Seagen Main Business Overview
11.12.5 Seagen Latest Developments
11.13 Eli Lilly
11.13.1 Eli Lilly Company Information
11.13.2 Eli Lilly Protein-based Therapeutics Product Offered
11.13.3 Eli Lilly Protein-based Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Eli Lilly Main Business Overview
11.13.5 Eli Lilly Latest Developments
11.14 Ono Pharmaceutical
11.14.1 Ono Pharmaceutical Company Information
11.14.2 Ono Pharmaceutical Protein-based Therapeutics Product Offered
11.14.3 Ono Pharmaceutical Protein-based Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Ono Pharmaceutical Main Business Overview
11.14.5 Ono Pharmaceutical Latest Developments
11.15 Pfizer
11.15.1 Pfizer Company Information
11.15.2 Pfizer Protein-based Therapeutics Product Offered
11.15.3 Pfizer Protein-based Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Pfizer Main Business Overview
11.15.5 Pfizer Latest Developments
11.16 Regeneron
11.16.1 Regeneron Company Information
11.16.2 Regeneron Protein-based Therapeutics Product Offered
11.16.3 Regeneron Protein-based Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Regeneron Main Business Overview
11.16.5 Regeneron Latest Developments
11.17 Innovent
11.17.1 Innovent Company Information
11.17.2 Innovent Protein-based Therapeutics Product Offered
11.17.3 Innovent Protein-based Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Innovent Main Business Overview
11.17.5 Innovent Latest Developments
11.18 Hengrui Medicine
11.18.1 Hengrui Medicine Company Information
11.18.2 Hengrui Medicine Protein-based Therapeutics Product Offered
11.18.3 Hengrui Medicine Protein-based Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Hengrui Medicine Main Business Overview
11.18.5 Hengrui Medicine Latest Developments
11.19 Sanofi
11.19.1 Sanofi Company Information
11.19.2 Sanofi Protein-based Therapeutics Product Offered
11.19.3 Sanofi Protein-based Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Sanofi Main Business Overview
11.19.5 Sanofi Latest Developments
11.20 Sobi
11.20.1 Sobi Company Information
11.20.2 Sobi Protein-based Therapeutics Product Offered
11.20.3 Sobi Protein-based Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Sobi Main Business Overview
11.20.5 Sobi Latest Developments
11.21 Kanghong Pharma
11.21.1 Kanghong Pharma Company Information
11.21.2 Kanghong Pharma Protein-based Therapeutics Product Offered
11.21.3 Kanghong Pharma Protein-based Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.21.4 Kanghong Pharma Main Business Overview
11.21.5 Kanghong Pharma Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Protein-based Therapeutics Market Size (2021-2032)
2.1.2 Protein-based Therapeutics Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Protein-based Therapeutics by Country/Region (2021, 2025 & 2032)
2.2 Protein-based Therapeutics Segment by Type
2.2.1 Antibody-based Drugs
2.2.2 Fc Fusion Proteins
2.2.3 Anticoagulants
2.2.4 Blood Factors
2.2.5 Other
2.2.6 Protein-based Therapeutics Market Size by Type
2.2.6.1 Protein-based Therapeutics Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.6.2 Global Protein-based Therapeutics Market Size Market Share by Type (2021-2026)
2.3 Protein-based Therapeutics Segment by Application
2.3.1 Immune Diseases
2.3.2 Cancer
2.3.3 Other
2.3.4 Protein-based Therapeutics Market Size by Application
2.3.4.1 Protein-based Therapeutics Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Protein-based Therapeutics Market Size Market Share by Application (2021-2026)
3 PROTEIN-BASED THERAPEUTICS MARKET SIZE BY PLAYER
3.1 Protein-based Therapeutics Market Size Market Share by Player
3.1.1 Global Protein-based Therapeutics Revenue by Player (2021-2026)
3.1.2 Global Protein-based Therapeutics Revenue Market Share by Player (2021-2026)
3.2 Global Protein-based Therapeutics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 PROTEIN-BASED THERAPEUTICS BY REGION
4.1 Protein-based Therapeutics Market Size by Region (2021-2026)
4.2 Global Protein-based Therapeutics Annual Revenue by Country/Region (2021-2026)
4.3 Americas Protein-based Therapeutics Market Size Growth (2021-2026)
4.4 APAC Protein-based Therapeutics Market Size Growth (2021-2026)
4.5 Europe Protein-based Therapeutics Market Size Growth (2021-2026)
4.6 Middle East & Africa Protein-based Therapeutics Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Protein-based Therapeutics Market Size by Country (2021-2026)
5.2 Americas Protein-based Therapeutics Market Size by Type (2021-2026)
5.3 Americas Protein-based Therapeutics Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Protein-based Therapeutics Market Size by Region (2021-2026)
6.2 APAC Protein-based Therapeutics Market Size by Type (2021-2026)
6.3 APAC Protein-based Therapeutics Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Protein-based Therapeutics Market Size by Country (2021-2026)
7.2 Europe Protein-based Therapeutics Market Size by Type (2021-2026)
7.3 Europe Protein-based Therapeutics Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Protein-based Therapeutics by Region (2021-2026)
8.2 Middle East & Africa Protein-based Therapeutics Market Size by Type (2021-2026)
8.3 Middle East & Africa Protein-based Therapeutics Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL PROTEIN-BASED THERAPEUTICS MARKET FORECAST
10.1 Global Protein-based Therapeutics Forecast by Region (2027-2032)
10.1.1 Global Protein-based Therapeutics Forecast by Region (2027-2032)
10.1.2 Americas Protein-based Therapeutics Forecast
10.1.3 APAC Protein-based Therapeutics Forecast
10.1.4 Europe Protein-based Therapeutics Forecast
10.1.5 Middle East & Africa Protein-based Therapeutics Forecast
10.2 Americas Protein-based Therapeutics Forecast by Country (2027-2032)
10.2.1 United States Market Protein-based Therapeutics Forecast
10.2.2 Canada Market Protein-based Therapeutics Forecast
10.2.3 Mexico Market Protein-based Therapeutics Forecast
10.2.4 Brazil Market Protein-based Therapeutics Forecast
10.3 APAC Protein-based Therapeutics Forecast by Region (2027-2032)
10.3.1 China Protein-based Therapeutics Market Forecast
10.3.2 Japan Market Protein-based Therapeutics Forecast
10.3.3 Korea Market Protein-based Therapeutics Forecast
10.3.4 Southeast Asia Market Protein-based Therapeutics Forecast
10.3.5 India Market Protein-based Therapeutics Forecast
10.3.6 Australia Market Protein-based Therapeutics Forecast
10.4 Europe Protein-based Therapeutics Forecast by Country (2027-2032)
10.4.1 Germany Market Protein-based Therapeutics Forecast
10.4.2 France Market Protein-based Therapeutics Forecast
10.4.3 UK Market Protein-based Therapeutics Forecast
10.4.4 Italy Market Protein-based Therapeutics Forecast
10.4.5 Russia Market Protein-based Therapeutics Forecast
10.5 Middle East & Africa Protein-based Therapeutics Forecast by Region (2027-2032)
10.5.1 Egypt Market Protein-based Therapeutics Forecast
10.5.2 South Africa Market Protein-based Therapeutics Forecast
10.5.3 Israel Market Protein-based Therapeutics Forecast
10.5.4 Turkey Market Protein-based Therapeutics Forecast
10.6 Global Protein-based Therapeutics Forecast by Type (2027-2032)
10.7 Global Protein-based Therapeutics Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Protein-based Therapeutics Forecast
11 KEY PLAYERS ANALYSIS
11.1 AbbVie
11.1.1 AbbVie Company Information
11.1.2 AbbVie Protein-based Therapeutics Product Offered
11.1.3 AbbVie Protein-based Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 AbbVie Main Business Overview
11.1.5 AbbVie Latest Developments
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Information
11.2.2 Johnson & Johnson Protein-based Therapeutics Product Offered
11.2.3 Johnson & Johnson Protein-based Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Johnson & Johnson Main Business Overview
11.2.5 Johnson & Johnson Latest Developments
11.3 Novartis
11.3.1 Novartis Company Information
11.3.2 Novartis Protein-based Therapeutics Product Offered
11.3.3 Novartis Protein-based Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 Novartis Main Business Overview
11.3.5 Novartis Latest Developments
11.4 Gilead Sciences
11.4.1 Gilead Sciences Company Information
11.4.2 Gilead Sciences Protein-based Therapeutics Product Offered
11.4.3 Gilead Sciences Protein-based Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Gilead Sciences Main Business Overview
11.4.5 Gilead Sciences Latest Developments
11.5 Roche
11.5.1 Roche Company Information
11.5.2 Roche Protein-based Therapeutics Product Offered
11.5.3 Roche Protein-based Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Roche Main Business Overview
11.5.5 Roche Latest Developments
11.6 Bristol-Myers Squibb
11.6.1 Bristol-Myers Squibb Company Information
11.6.2 Bristol-Myers Squibb Protein-based Therapeutics Product Offered
11.6.3 Bristol-Myers Squibb Protein-based Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 Bristol-Myers Squibb Main Business Overview
11.6.5 Bristol-Myers Squibb Latest Developments
11.7 Amgen
11.7.1 Amgen Company Information
11.7.2 Amgen Protein-based Therapeutics Product Offered
11.7.3 Amgen Protein-based Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Amgen Main Business Overview
11.7.5 Amgen Latest Developments
11.8 AstraZeneca
11.8.1 AstraZeneca Company Information
11.8.2 AstraZeneca Protein-based Therapeutics Product Offered
11.8.3 AstraZeneca Protein-based Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 AstraZeneca Main Business Overview
11.8.5 AstraZeneca Latest Developments
11.9 Merck & Co
11.9.1 Merck & Co Company Information
11.9.2 Merck & Co Protein-based Therapeutics Product Offered
11.9.3 Merck & Co Protein-based Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Merck & Co Main Business Overview
11.9.5 Merck & Co Latest Developments
11.10 Takeda
11.10.1 Takeda Company Information
11.10.2 Takeda Protein-based Therapeutics Product Offered
11.10.3 Takeda Protein-based Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Takeda Main Business Overview
11.10.5 Takeda Latest Developments
11.11 Merck KGaA
11.11.1 Merck KGaA Company Information
11.11.2 Merck KGaA Protein-based Therapeutics Product Offered
11.11.3 Merck KGaA Protein-based Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Merck KGaA Main Business Overview
11.11.5 Merck KGaA Latest Developments
11.12 Seagen
11.12.1 Seagen Company Information
11.12.2 Seagen Protein-based Therapeutics Product Offered
11.12.3 Seagen Protein-based Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Seagen Main Business Overview
11.12.5 Seagen Latest Developments
11.13 Eli Lilly
11.13.1 Eli Lilly Company Information
11.13.2 Eli Lilly Protein-based Therapeutics Product Offered
11.13.3 Eli Lilly Protein-based Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Eli Lilly Main Business Overview
11.13.5 Eli Lilly Latest Developments
11.14 Ono Pharmaceutical
11.14.1 Ono Pharmaceutical Company Information
11.14.2 Ono Pharmaceutical Protein-based Therapeutics Product Offered
11.14.3 Ono Pharmaceutical Protein-based Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.14.4 Ono Pharmaceutical Main Business Overview
11.14.5 Ono Pharmaceutical Latest Developments
11.15 Pfizer
11.15.1 Pfizer Company Information
11.15.2 Pfizer Protein-based Therapeutics Product Offered
11.15.3 Pfizer Protein-based Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.15.4 Pfizer Main Business Overview
11.15.5 Pfizer Latest Developments
11.16 Regeneron
11.16.1 Regeneron Company Information
11.16.2 Regeneron Protein-based Therapeutics Product Offered
11.16.3 Regeneron Protein-based Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.16.4 Regeneron Main Business Overview
11.16.5 Regeneron Latest Developments
11.17 Innovent
11.17.1 Innovent Company Information
11.17.2 Innovent Protein-based Therapeutics Product Offered
11.17.3 Innovent Protein-based Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.17.4 Innovent Main Business Overview
11.17.5 Innovent Latest Developments
11.18 Hengrui Medicine
11.18.1 Hengrui Medicine Company Information
11.18.2 Hengrui Medicine Protein-based Therapeutics Product Offered
11.18.3 Hengrui Medicine Protein-based Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.18.4 Hengrui Medicine Main Business Overview
11.18.5 Hengrui Medicine Latest Developments
11.19 Sanofi
11.19.1 Sanofi Company Information
11.19.2 Sanofi Protein-based Therapeutics Product Offered
11.19.3 Sanofi Protein-based Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.19.4 Sanofi Main Business Overview
11.19.5 Sanofi Latest Developments
11.20 Sobi
11.20.1 Sobi Company Information
11.20.2 Sobi Protein-based Therapeutics Product Offered
11.20.3 Sobi Protein-based Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.20.4 Sobi Main Business Overview
11.20.5 Sobi Latest Developments
11.21 Kanghong Pharma
11.21.1 Kanghong Pharma Company Information
11.21.2 Kanghong Pharma Protein-based Therapeutics Product Offered
11.21.3 Kanghong Pharma Protein-based Therapeutics Revenue, Gross Margin and Market Share (2021-2026)
11.21.4 Kanghong Pharma Main Business Overview
11.21.5 Kanghong Pharma Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Protein-based Therapeutics Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Protein-based Therapeutics Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Antibody-based Drugs
Table 4. Major Players of Fc Fusion Proteins
Table 5. Major Players of Anticoagulants
Table 6. Major Players of Blood Factors
Table 7. Major Players of Other
Table 8. Protein-based Therapeutics Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Protein-based Therapeutics Market Size by Type (2021-2026) & ($ millions)
Table 10. Global Protein-based Therapeutics Market Size Market Share by Type (2021-2026)
Table 11. Protein-based Therapeutics Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 12. Global Protein-based Therapeutics Market Size by Application (2021-2026) & ($ millions)
Table 13. Global Protein-based Therapeutics Market Size Market Share by Application (2021-2026)
Table 14. Global Protein-based Therapeutics Revenue by Player (2021-2026) & ($ millions)
Table 15. Global Protein-based Therapeutics Revenue Market Share by Player (2021-2026)
Table 16. Protein-based Therapeutics Key Players Head office and Products Offered
Table 17. Protein-based Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Protein-based Therapeutics Market Size by Region (2021-2026) & ($ millions)
Table 21. Global Protein-based Therapeutics Market Size Market Share by Region (2021-2026)
Table 22. Global Protein-based Therapeutics Revenue by Country/Region (2021-2026) & ($ millions)
Table 23. Global Protein-based Therapeutics Revenue Market Share by Country/Region (2021-2026)
Table 24. Americas Protein-based Therapeutics Market Size by Country (2021-2026) & ($ millions)
Table 25. Americas Protein-based Therapeutics Market Size Market Share by Country (2021-2026)
Table 26. Americas Protein-based Therapeutics Market Size by Type (2021-2026) & ($ millions)
Table 27. Americas Protein-based Therapeutics Market Size Market Share by Type (2021-2026)
Table 28. Americas Protein-based Therapeutics Market Size by Application (2021-2026) & ($ millions)
Table 29. Americas Protein-based Therapeutics Market Size Market Share by Application (2021-2026)
Table 30. APAC Protein-based Therapeutics Market Size by Region (2021-2026) & ($ millions)
Table 31. APAC Protein-based Therapeutics Market Size Market Share by Region (2021-2026)
Table 32. APAC Protein-based Therapeutics Market Size by Type (2021-2026) & ($ millions)
Table 33. APAC Protein-based Therapeutics Market Size by Application (2021-2026) & ($ millions)
Table 34. Europe Protein-based Therapeutics Market Size by Country (2021-2026) & ($ millions)
Table 35. Europe Protein-based Therapeutics Market Size Market Share by Country (2021-2026)
Table 36. Europe Protein-based Therapeutics Market Size by Type (2021-2026) & ($ millions)
Table 37. Europe Protein-based Therapeutics Market Size by Application (2021-2026) & ($ millions)
Table 38. Middle East & Africa Protein-based Therapeutics Market Size by Region (2021-2026) & ($ millions)
Table 39. Middle East & Africa Protein-based Therapeutics Market Size by Type (2021-2026) & ($ millions)
Table 40. Middle East & Africa Protein-based Therapeutics Market Size by Application (2021-2026) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Protein-based Therapeutics
Table 42. Key Market Challenges & Risks of Protein-based Therapeutics
Table 43. Key Industry Trends of Protein-based Therapeutics
Table 44. Global Protein-based Therapeutics Market Size Forecast by Region (2027-2032) & ($ millions)
Table 45. Global Protein-based Therapeutics Market Size Market Share Forecast by Region (2027-2032)
Table 46. Global Protein-based Therapeutics Market Size Forecast by Type (2027-2032) & ($ millions)
Table 47. Global Protein-based Therapeutics Market Size Forecast by Application (2027-2032) & ($ millions)
Table 48. AbbVie Details, Company Type, Protein-based Therapeutics Area Served and Its Competitors
Table 49. AbbVie Protein-based Therapeutics Product Offered
Table 50. AbbVie Protein-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 51. AbbVie Main Business
Table 52. AbbVie Latest Developments
Table 53. Johnson & Johnson Details, Company Type, Protein-based Therapeutics Area Served and Its Competitors
Table 54. Johnson & Johnson Protein-based Therapeutics Product Offered
Table 55. Johnson & Johnson Protein-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 56. Johnson & Johnson Main Business
Table 57. Johnson & Johnson Latest Developments
Table 58. Novartis Details, Company Type, Protein-based Therapeutics Area Served and Its Competitors
Table 59. Novartis Protein-based Therapeutics Product Offered
Table 60. Novartis Protein-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 61. Novartis Main Business
Table 62. Novartis Latest Developments
Table 63. Gilead Sciences Details, Company Type, Protein-based Therapeutics Area Served and Its Competitors
Table 64. Gilead Sciences Protein-based Therapeutics Product Offered
Table 65. Gilead Sciences Protein-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 66. Gilead Sciences Main Business
Table 67. Gilead Sciences Latest Developments
Table 68. Roche Details, Company Type, Protein-based Therapeutics Area Served and Its Competitors
Table 69. Roche Protein-based Therapeutics Product Offered
Table 70. Roche Protein-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. Roche Main Business
Table 72. Roche Latest Developments
Table 73. Bristol-Myers Squibb Details, Company Type, Protein-based Therapeutics Area Served and Its Competitors
Table 74. Bristol-Myers Squibb Protein-based Therapeutics Product Offered
Table 75. Bristol-Myers Squibb Protein-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 76. Bristol-Myers Squibb Main Business
Table 77. Bristol-Myers Squibb Latest Developments
Table 78. Amgen Details, Company Type, Protein-based Therapeutics Area Served and Its Competitors
Table 79. Amgen Protein-based Therapeutics Product Offered
Table 80. Amgen Protein-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 81. Amgen Main Business
Table 82. Amgen Latest Developments
Table 83. AstraZeneca Details, Company Type, Protein-based Therapeutics Area Served and Its Competitors
Table 84. AstraZeneca Protein-based Therapeutics Product Offered
Table 85. AstraZeneca Protein-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 86. AstraZeneca Main Business
Table 87. AstraZeneca Latest Developments
Table 88. Merck & Co Details, Company Type, Protein-based Therapeutics Area Served and Its Competitors
Table 89. Merck & Co Protein-based Therapeutics Product Offered
Table 90. Merck & Co Protein-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 91. Merck & Co Main Business
Table 92. Merck & Co Latest Developments
Table 93. Takeda Details, Company Type, Protein-based Therapeutics Area Served and Its Competitors
Table 94. Takeda Protein-based Therapeutics Product Offered
Table 95. Takeda Protein-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 96. Takeda Main Business
Table 97. Takeda Latest Developments
Table 98. Merck KGaA Details, Company Type, Protein-based Therapeutics Area Served and Its Competitors
Table 99. Merck KGaA Protein-based Therapeutics Product Offered
Table 100. Merck KGaA Protein-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 101. Merck KGaA Main Business
Table 102. Merck KGaA Latest Developments
Table 103. Seagen Details, Company Type, Protein-based Therapeutics Area Served and Its Competitors
Table 104. Seagen Protein-based Therapeutics Product Offered
Table 105. Seagen Protein-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 106. Seagen Main Business
Table 107. Seagen Latest Developments
Table 108. Eli Lilly Details, Company Type, Protein-based Therapeutics Area Served and Its Competitors
Table 109. Eli Lilly Protein-based Therapeutics Product Offered
Table 110. Eli Lilly Protein-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 111. Eli Lilly Main Business
Table 112. Eli Lilly Latest Developments
Table 113. Ono Pharmaceutical Details, Company Type, Protein-based Therapeutics Area Served and Its Competitors
Table 114. Ono Pharmaceutical Protein-based Therapeutics Product Offered
Table 115. Ono Pharmaceutical Protein-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 116. Ono Pharmaceutical Main Business
Table 117. Ono Pharmaceutical Latest Developments
Table 118. Pfizer Details, Company Type, Protein-based Therapeutics Area Served and Its Competitors
Table 119. Pfizer Protein-based Therapeutics Product Offered
Table 120. Pfizer Protein-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 121. Pfizer Main Business
Table 122. Pfizer Latest Developments
Table 123. Regeneron Details, Company Type, Protein-based Therapeutics Area Served and Its Competitors
Table 124. Regeneron Protein-based Therapeutics Product Offered
Table 125. Regeneron Protein-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 126. Regeneron Main Business
Table 127. Regeneron Latest Developments
Table 128. Innovent Details, Company Type, Protein-based Therapeutics Area Served and Its Competitors
Table 129. Innovent Protein-based Therapeutics Product Offered
Table 130. Innovent Protein-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 131. Innovent Main Business
Table 132. Innovent Latest Developments
Table 133. Hengrui Medicine Details, Company Type, Protein-based Therapeutics Area Served and Its Competitors
Table 134. Hengrui Medicine Protein-based Therapeutics Product Offered
Table 135. Hengrui Medicine Protein-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 136. Hengrui Medicine Main Business
Table 137. Hengrui Medicine Latest Developments
Table 138. Sanofi Details, Company Type, Protein-based Therapeutics Area Served and Its Competitors
Table 139. Sanofi Protein-based Therapeutics Product Offered
Table 140. Sanofi Protein-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 141. Sanofi Main Business
Table 142. Sanofi Latest Developments
Table 143. Sobi Details, Company Type, Protein-based Therapeutics Area Served and Its Competitors
Table 144. Sobi Protein-based Therapeutics Product Offered
Table 145. Sobi Protein-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 146. Sobi Main Business
Table 147. Sobi Latest Developments
Table 148. Kanghong Pharma Details, Company Type, Protein-based Therapeutics Area Served and Its Competitors
Table 149. Kanghong Pharma Protein-based Therapeutics Product Offered
Table 150. Kanghong Pharma Protein-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 151. Kanghong Pharma Main Business
Table 152. Kanghong Pharma Latest Developments
Table 1. Protein-based Therapeutics Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Protein-based Therapeutics Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Antibody-based Drugs
Table 4. Major Players of Fc Fusion Proteins
Table 5. Major Players of Anticoagulants
Table 6. Major Players of Blood Factors
Table 7. Major Players of Other
Table 8. Protein-based Therapeutics Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 9. Global Protein-based Therapeutics Market Size by Type (2021-2026) & ($ millions)
Table 10. Global Protein-based Therapeutics Market Size Market Share by Type (2021-2026)
Table 11. Protein-based Therapeutics Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 12. Global Protein-based Therapeutics Market Size by Application (2021-2026) & ($ millions)
Table 13. Global Protein-based Therapeutics Market Size Market Share by Application (2021-2026)
Table 14. Global Protein-based Therapeutics Revenue by Player (2021-2026) & ($ millions)
Table 15. Global Protein-based Therapeutics Revenue Market Share by Player (2021-2026)
Table 16. Protein-based Therapeutics Key Players Head office and Products Offered
Table 17. Protein-based Therapeutics Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 18. New Products and Potential Entrants
Table 19. Mergers & Acquisitions, Expansion
Table 20. Global Protein-based Therapeutics Market Size by Region (2021-2026) & ($ millions)
Table 21. Global Protein-based Therapeutics Market Size Market Share by Region (2021-2026)
Table 22. Global Protein-based Therapeutics Revenue by Country/Region (2021-2026) & ($ millions)
Table 23. Global Protein-based Therapeutics Revenue Market Share by Country/Region (2021-2026)
Table 24. Americas Protein-based Therapeutics Market Size by Country (2021-2026) & ($ millions)
Table 25. Americas Protein-based Therapeutics Market Size Market Share by Country (2021-2026)
Table 26. Americas Protein-based Therapeutics Market Size by Type (2021-2026) & ($ millions)
Table 27. Americas Protein-based Therapeutics Market Size Market Share by Type (2021-2026)
Table 28. Americas Protein-based Therapeutics Market Size by Application (2021-2026) & ($ millions)
Table 29. Americas Protein-based Therapeutics Market Size Market Share by Application (2021-2026)
Table 30. APAC Protein-based Therapeutics Market Size by Region (2021-2026) & ($ millions)
Table 31. APAC Protein-based Therapeutics Market Size Market Share by Region (2021-2026)
Table 32. APAC Protein-based Therapeutics Market Size by Type (2021-2026) & ($ millions)
Table 33. APAC Protein-based Therapeutics Market Size by Application (2021-2026) & ($ millions)
Table 34. Europe Protein-based Therapeutics Market Size by Country (2021-2026) & ($ millions)
Table 35. Europe Protein-based Therapeutics Market Size Market Share by Country (2021-2026)
Table 36. Europe Protein-based Therapeutics Market Size by Type (2021-2026) & ($ millions)
Table 37. Europe Protein-based Therapeutics Market Size by Application (2021-2026) & ($ millions)
Table 38. Middle East & Africa Protein-based Therapeutics Market Size by Region (2021-2026) & ($ millions)
Table 39. Middle East & Africa Protein-based Therapeutics Market Size by Type (2021-2026) & ($ millions)
Table 40. Middle East & Africa Protein-based Therapeutics Market Size by Application (2021-2026) & ($ millions)
Table 41. Key Market Drivers & Growth Opportunities of Protein-based Therapeutics
Table 42. Key Market Challenges & Risks of Protein-based Therapeutics
Table 43. Key Industry Trends of Protein-based Therapeutics
Table 44. Global Protein-based Therapeutics Market Size Forecast by Region (2027-2032) & ($ millions)
Table 45. Global Protein-based Therapeutics Market Size Market Share Forecast by Region (2027-2032)
Table 46. Global Protein-based Therapeutics Market Size Forecast by Type (2027-2032) & ($ millions)
Table 47. Global Protein-based Therapeutics Market Size Forecast by Application (2027-2032) & ($ millions)
Table 48. AbbVie Details, Company Type, Protein-based Therapeutics Area Served and Its Competitors
Table 49. AbbVie Protein-based Therapeutics Product Offered
Table 50. AbbVie Protein-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 51. AbbVie Main Business
Table 52. AbbVie Latest Developments
Table 53. Johnson & Johnson Details, Company Type, Protein-based Therapeutics Area Served and Its Competitors
Table 54. Johnson & Johnson Protein-based Therapeutics Product Offered
Table 55. Johnson & Johnson Protein-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 56. Johnson & Johnson Main Business
Table 57. Johnson & Johnson Latest Developments
Table 58. Novartis Details, Company Type, Protein-based Therapeutics Area Served and Its Competitors
Table 59. Novartis Protein-based Therapeutics Product Offered
Table 60. Novartis Protein-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 61. Novartis Main Business
Table 62. Novartis Latest Developments
Table 63. Gilead Sciences Details, Company Type, Protein-based Therapeutics Area Served and Its Competitors
Table 64. Gilead Sciences Protein-based Therapeutics Product Offered
Table 65. Gilead Sciences Protein-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 66. Gilead Sciences Main Business
Table 67. Gilead Sciences Latest Developments
Table 68. Roche Details, Company Type, Protein-based Therapeutics Area Served and Its Competitors
Table 69. Roche Protein-based Therapeutics Product Offered
Table 70. Roche Protein-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 71. Roche Main Business
Table 72. Roche Latest Developments
Table 73. Bristol-Myers Squibb Details, Company Type, Protein-based Therapeutics Area Served and Its Competitors
Table 74. Bristol-Myers Squibb Protein-based Therapeutics Product Offered
Table 75. Bristol-Myers Squibb Protein-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 76. Bristol-Myers Squibb Main Business
Table 77. Bristol-Myers Squibb Latest Developments
Table 78. Amgen Details, Company Type, Protein-based Therapeutics Area Served and Its Competitors
Table 79. Amgen Protein-based Therapeutics Product Offered
Table 80. Amgen Protein-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 81. Amgen Main Business
Table 82. Amgen Latest Developments
Table 83. AstraZeneca Details, Company Type, Protein-based Therapeutics Area Served and Its Competitors
Table 84. AstraZeneca Protein-based Therapeutics Product Offered
Table 85. AstraZeneca Protein-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 86. AstraZeneca Main Business
Table 87. AstraZeneca Latest Developments
Table 88. Merck & Co Details, Company Type, Protein-based Therapeutics Area Served and Its Competitors
Table 89. Merck & Co Protein-based Therapeutics Product Offered
Table 90. Merck & Co Protein-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 91. Merck & Co Main Business
Table 92. Merck & Co Latest Developments
Table 93. Takeda Details, Company Type, Protein-based Therapeutics Area Served and Its Competitors
Table 94. Takeda Protein-based Therapeutics Product Offered
Table 95. Takeda Protein-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 96. Takeda Main Business
Table 97. Takeda Latest Developments
Table 98. Merck KGaA Details, Company Type, Protein-based Therapeutics Area Served and Its Competitors
Table 99. Merck KGaA Protein-based Therapeutics Product Offered
Table 100. Merck KGaA Protein-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 101. Merck KGaA Main Business
Table 102. Merck KGaA Latest Developments
Table 103. Seagen Details, Company Type, Protein-based Therapeutics Area Served and Its Competitors
Table 104. Seagen Protein-based Therapeutics Product Offered
Table 105. Seagen Protein-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 106. Seagen Main Business
Table 107. Seagen Latest Developments
Table 108. Eli Lilly Details, Company Type, Protein-based Therapeutics Area Served and Its Competitors
Table 109. Eli Lilly Protein-based Therapeutics Product Offered
Table 110. Eli Lilly Protein-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 111. Eli Lilly Main Business
Table 112. Eli Lilly Latest Developments
Table 113. Ono Pharmaceutical Details, Company Type, Protein-based Therapeutics Area Served and Its Competitors
Table 114. Ono Pharmaceutical Protein-based Therapeutics Product Offered
Table 115. Ono Pharmaceutical Protein-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 116. Ono Pharmaceutical Main Business
Table 117. Ono Pharmaceutical Latest Developments
Table 118. Pfizer Details, Company Type, Protein-based Therapeutics Area Served and Its Competitors
Table 119. Pfizer Protein-based Therapeutics Product Offered
Table 120. Pfizer Protein-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 121. Pfizer Main Business
Table 122. Pfizer Latest Developments
Table 123. Regeneron Details, Company Type, Protein-based Therapeutics Area Served and Its Competitors
Table 124. Regeneron Protein-based Therapeutics Product Offered
Table 125. Regeneron Protein-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 126. Regeneron Main Business
Table 127. Regeneron Latest Developments
Table 128. Innovent Details, Company Type, Protein-based Therapeutics Area Served and Its Competitors
Table 129. Innovent Protein-based Therapeutics Product Offered
Table 130. Innovent Protein-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 131. Innovent Main Business
Table 132. Innovent Latest Developments
Table 133. Hengrui Medicine Details, Company Type, Protein-based Therapeutics Area Served and Its Competitors
Table 134. Hengrui Medicine Protein-based Therapeutics Product Offered
Table 135. Hengrui Medicine Protein-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 136. Hengrui Medicine Main Business
Table 137. Hengrui Medicine Latest Developments
Table 138. Sanofi Details, Company Type, Protein-based Therapeutics Area Served and Its Competitors
Table 139. Sanofi Protein-based Therapeutics Product Offered
Table 140. Sanofi Protein-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 141. Sanofi Main Business
Table 142. Sanofi Latest Developments
Table 143. Sobi Details, Company Type, Protein-based Therapeutics Area Served and Its Competitors
Table 144. Sobi Protein-based Therapeutics Product Offered
Table 145. Sobi Protein-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 146. Sobi Main Business
Table 147. Sobi Latest Developments
Table 148. Kanghong Pharma Details, Company Type, Protein-based Therapeutics Area Served and Its Competitors
Table 149. Kanghong Pharma Protein-based Therapeutics Product Offered
Table 150. Kanghong Pharma Protein-based Therapeutics Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 151. Kanghong Pharma Main Business
Table 152. Kanghong Pharma Latest Developments
LIST OF FIGURES
Figure 1. Protein-based Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Protein-based Therapeutics Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Protein-based Therapeutics Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Protein-based Therapeutics Sales Market Share by Country/Region (2025)
Figure 8. Protein-based Therapeutics Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Protein-based Therapeutics Market Size Market Share by Type in 2025
Figure 10. Protein-based Therapeutics in Immune Diseases
Figure 11. Global Protein-based Therapeutics Market: Immune Diseases (2021-2026) & ($ millions)
Figure 12. Protein-based Therapeutics in Cancer
Figure 13. Global Protein-based Therapeutics Market: Cancer (2021-2026) & ($ millions)
Figure 14. Protein-based Therapeutics in Other
Figure 15. Global Protein-based Therapeutics Market: Other (2021-2026) & ($ millions)
Figure 16. Global Protein-based Therapeutics Market Size Market Share by Application in 2025
Figure 17. Global Protein-based Therapeutics Revenue Market Share by Player in 2025
Figure 18. Global Protein-based Therapeutics Market Size Market Share by Region (2021-2026)
Figure 19. Americas Protein-based Therapeutics Market Size 2021-2026 ($ millions)
Figure 20. APAC Protein-based Therapeutics Market Size 2021-2026 ($ millions)
Figure 21. Europe Protein-based Therapeutics Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Protein-based Therapeutics Market Size 2021-2026 ($ millions)
Figure 23. Americas Protein-based Therapeutics Value Market Share by Country in 2025
Figure 24. United States Protein-based Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Protein-based Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Protein-based Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Protein-based Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Protein-based Therapeutics Market Size Market Share by Region in 2025
Figure 29. APAC Protein-based Therapeutics Market Size Market Share by Type (2021-2026)
Figure 30. APAC Protein-based Therapeutics Market Size Market Share by Application (2021-2026)
Figure 31. China Protein-based Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Protein-based Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Protein-based Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Protein-based Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 35. India Protein-based Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Protein-based Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Protein-based Therapeutics Market Size Market Share by Country in 2025
Figure 38. Europe Protein-based Therapeutics Market Size Market Share by Type (2021-2026)
Figure 39. Europe Protein-based Therapeutics Market Size Market Share by Application (2021-2026)
Figure 40. Germany Protein-based Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 41. France Protein-based Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Protein-based Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Protein-based Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Protein-based Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Protein-based Therapeutics Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Protein-based Therapeutics Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Protein-based Therapeutics Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Protein-based Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Protein-based Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Protein-based Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Protein-based Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Protein-based Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Protein-based Therapeutics Market Size 2027-2032 ($ millions)
Figure 54. APAC Protein-based Therapeutics Market Size 2027-2032 ($ millions)
Figure 55. Europe Protein-based Therapeutics Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Protein-based Therapeutics Market Size 2027-2032 ($ millions)
Figure 57. United States Protein-based Therapeutics Market Size 2027-2032 ($ millions)
Figure 58. Canada Protein-based Therapeutics Market Size 2027-2032 ($ millions)
Figure 59. Mexico Protein-based Therapeutics Market Size 2027-2032 ($ millions)
Figure 60. Brazil Protein-based Therapeutics Market Size 2027-2032 ($ millions)
Figure 61. China Protein-based Therapeutics Market Size 2027-2032 ($ millions)
Figure 62. Japan Protein-based Therapeutics Market Size 2027-2032 ($ millions)
Figure 63. Korea Protein-based Therapeutics Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Protein-based Therapeutics Market Size 2027-2032 ($ millions)
Figure 65. India Protein-based Therapeutics Market Size 2027-2032 ($ millions)
Figure 66. Australia Protein-based Therapeutics Market Size 2027-2032 ($ millions)
Figure 67. Germany Protein-based Therapeutics Market Size 2027-2032 ($ millions)
Figure 68. France Protein-based Therapeutics Market Size 2027-2032 ($ millions)
Figure 69. UK Protein-based Therapeutics Market Size 2027-2032 ($ millions)
Figure 70. Italy Protein-based Therapeutics Market Size 2027-2032 ($ millions)
Figure 71. Russia Protein-based Therapeutics Market Size 2027-2032 ($ millions)
Figure 72. Egypt Protein-based Therapeutics Market Size 2027-2032 ($ millions)
Figure 73. South Africa Protein-based Therapeutics Market Size 2027-2032 ($ millions)
Figure 74. Israel Protein-based Therapeutics Market Size 2027-2032 ($ millions)
Figure 75. Turkey Protein-based Therapeutics Market Size 2027-2032 ($ millions)
Figure 76. Global Protein-based Therapeutics Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Protein-based Therapeutics Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Protein-based Therapeutics Market Size 2027-2032 ($ millions)
Figure 1. Protein-based Therapeutics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Protein-based Therapeutics Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Protein-based Therapeutics Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Protein-based Therapeutics Sales Market Share by Country/Region (2025)
Figure 8. Protein-based Therapeutics Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Protein-based Therapeutics Market Size Market Share by Type in 2025
Figure 10. Protein-based Therapeutics in Immune Diseases
Figure 11. Global Protein-based Therapeutics Market: Immune Diseases (2021-2026) & ($ millions)
Figure 12. Protein-based Therapeutics in Cancer
Figure 13. Global Protein-based Therapeutics Market: Cancer (2021-2026) & ($ millions)
Figure 14. Protein-based Therapeutics in Other
Figure 15. Global Protein-based Therapeutics Market: Other (2021-2026) & ($ millions)
Figure 16. Global Protein-based Therapeutics Market Size Market Share by Application in 2025
Figure 17. Global Protein-based Therapeutics Revenue Market Share by Player in 2025
Figure 18. Global Protein-based Therapeutics Market Size Market Share by Region (2021-2026)
Figure 19. Americas Protein-based Therapeutics Market Size 2021-2026 ($ millions)
Figure 20. APAC Protein-based Therapeutics Market Size 2021-2026 ($ millions)
Figure 21. Europe Protein-based Therapeutics Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Protein-based Therapeutics Market Size 2021-2026 ($ millions)
Figure 23. Americas Protein-based Therapeutics Value Market Share by Country in 2025
Figure 24. United States Protein-based Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Protein-based Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Protein-based Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Protein-based Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Protein-based Therapeutics Market Size Market Share by Region in 2025
Figure 29. APAC Protein-based Therapeutics Market Size Market Share by Type (2021-2026)
Figure 30. APAC Protein-based Therapeutics Market Size Market Share by Application (2021-2026)
Figure 31. China Protein-based Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Protein-based Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Protein-based Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Protein-based Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 35. India Protein-based Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Protein-based Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Protein-based Therapeutics Market Size Market Share by Country in 2025
Figure 38. Europe Protein-based Therapeutics Market Size Market Share by Type (2021-2026)
Figure 39. Europe Protein-based Therapeutics Market Size Market Share by Application (2021-2026)
Figure 40. Germany Protein-based Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 41. France Protein-based Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Protein-based Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Protein-based Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Protein-based Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Protein-based Therapeutics Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Protein-based Therapeutics Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Protein-based Therapeutics Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Protein-based Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Protein-based Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Protein-based Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Protein-based Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Protein-based Therapeutics Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Protein-based Therapeutics Market Size 2027-2032 ($ millions)
Figure 54. APAC Protein-based Therapeutics Market Size 2027-2032 ($ millions)
Figure 55. Europe Protein-based Therapeutics Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Protein-based Therapeutics Market Size 2027-2032 ($ millions)
Figure 57. United States Protein-based Therapeutics Market Size 2027-2032 ($ millions)
Figure 58. Canada Protein-based Therapeutics Market Size 2027-2032 ($ millions)
Figure 59. Mexico Protein-based Therapeutics Market Size 2027-2032 ($ millions)
Figure 60. Brazil Protein-based Therapeutics Market Size 2027-2032 ($ millions)
Figure 61. China Protein-based Therapeutics Market Size 2027-2032 ($ millions)
Figure 62. Japan Protein-based Therapeutics Market Size 2027-2032 ($ millions)
Figure 63. Korea Protein-based Therapeutics Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Protein-based Therapeutics Market Size 2027-2032 ($ millions)
Figure 65. India Protein-based Therapeutics Market Size 2027-2032 ($ millions)
Figure 66. Australia Protein-based Therapeutics Market Size 2027-2032 ($ millions)
Figure 67. Germany Protein-based Therapeutics Market Size 2027-2032 ($ millions)
Figure 68. France Protein-based Therapeutics Market Size 2027-2032 ($ millions)
Figure 69. UK Protein-based Therapeutics Market Size 2027-2032 ($ millions)
Figure 70. Italy Protein-based Therapeutics Market Size 2027-2032 ($ millions)
Figure 71. Russia Protein-based Therapeutics Market Size 2027-2032 ($ millions)
Figure 72. Egypt Protein-based Therapeutics Market Size 2027-2032 ($ millions)
Figure 73. South Africa Protein-based Therapeutics Market Size 2027-2032 ($ millions)
Figure 74. Israel Protein-based Therapeutics Market Size 2027-2032 ($ millions)
Figure 75. Turkey Protein-based Therapeutics Market Size 2027-2032 ($ millions)
Figure 76. Global Protein-based Therapeutics Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Protein-based Therapeutics Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Protein-based Therapeutics Market Size 2027-2032 ($ millions)
